Topically applicable oil-in-water emulsions and dermatological applications thereof

• US 20080207570A1
• Filed: 02/08/2008
• Published: 08/28/2008
• Est. Priority Date: 08/11/2005
• Status: Abandoned Application

• Current Assignee: Galderma SA (Switzerland) (Galderma Holding SA)
• Original Assignee: L'Oreal SA
• Inventors: Segura-Orsoni, Sandrine
• Application Number:
  US12/068,670
• Publication Number:
  US 20080207570A1
• Time in Patent Office: Days
• US Class Current: 514/168
• CPC Class Codes: A61K 47/10 Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
• CPC Class Codes: A61K 47/14 Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
• CPC Class Codes: A61K 9/0014 Skin, i.e. galenical aspects of topical compositions non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00
• CPC Class Codes: A61P 17/00 Drugs for dermatological disorders
• CPC Class Codes: A61P 17/06 Antipsoriatics

Abstract

Novel topically applicable oil-in-water emulsions, with a high proportion of oily phase in the inner phase, combine the occlusive and emollient properties of an ointment without having the drawbacks of a greasy feel, while at the same time promoting the therapeutic properties of a biologically active agent contained therein; such emulsions are especially useful for the treatment of dermatological diseases, conditions or afflictions, notably psoriasis.

Claims

1. A topically applicable oil-in-water emulsion containing at least one biologically active agent and also comprising:

a) a fatty phase, the amount thereof ranging from about 35% to 50% by weight;

b) from about 1% to 15% by weight of a nonionic emulsifying system;

c) from about 1% to 30% by weight of at least one propenetrating agent; and

d) from about 5% to 50% by weight of water.

2. The oil-in-water emulsion as defined by claim 1, in which the fatty phase consists essentially of emollients, waxes and fatty alcohols.

3. The oil-in-water emulsion as defined by claim 1, in which the nonionic emulsifying system comprises at least one nonionic surfactant having an HLB of greater than approximately 10 and at least one nonionic surfactant having an HLB of less than approximately 10.

4. The oil-in-water emulsion as defined by claim 1, in which the emulsifying system comprises the glyceryl monostearate/ceteareth surfactant couple.

5. The oil-in-water emulsion as defined by claim 1, in which the propenetrating agent is selected from among propylene glycol, dipropylene glycol, propylene glycol dipelargonate, lauroglycol, ethoxydiglycol, urea, acetone, oleic acid, and mixtures thereof.

6. The oil-in-water emulsion as defined by claim 1, in which the biologically active agent is for the treatment and/or prevention of skin diseases.

7. The oil-in-water-emulsion as defined by claim 1, in which the biologically active agent comprises a corticosteroid.

8. The oil-in-water emulsion as defined by claim 7, in which the biologically active agent comprises clobetasol 17-propionate, desonide or betamethasone valerate.

9. The oil-in-water emulsion as defined by claim 1, in which the biologically active agent comprises a retinoid.

10. The oil-in-water emulsion as defined by claim 1, in which the biologically active agent comprises a vitamin D analogue.

11. The oil-in-water emulsion as defined by claim 1, in which the amount of water is from approximately 30% by weight of the emulsion.

12. The oil-in-water emulsion as defined by claim 1, further comprising one or more additives.

13. The oil-in-water emulsion as defined by claim 12, further comprising at least one additive selected from the group consisting of sequestering agents, antioxidants, sunscreens, preservatives, fillers, electrolytes, humectants, pH buffers, dyes, inorganic or organic acids or bases, fragrances, essential oils, active cosmetic agents, moisturizers, vitamins, sphingolipids, self-tanning compounds, gelling agents, and agents for soothing and protecting the skin.

14. The oil-in-water emulsion as defined by claim 1, comprising:

a) from about 35% to 45% by weight of a fatty phase;

b) from about 5% to 15% by weight of a nonionic emulsifying system;

c) from about 15% to 20% by weight of at least one propenetrating agent;

d) at least one additives;

e) from about 0.01% to 0.5% by weight of at least one biologically active agent; and

f) from about 5% to 50% by weight of water.

15. A method for preparing an oil-in-water emulsion as defined by claim 1, comprising the steps of:

a. dissolution and/or dispersion in water, with stirring, of at least one propenetrating agent and of, optionally, at least one additive, at a temperature of from 60°

C. and 95°

C., until a homogeneous aqueous phase is obtained;

b. incorporation, with stirring, of the aqueous phase into the fatty phase, in which the emulsifier has been solubilized, preheated to a temperature of from 60°

C. and 95°

C.; and

c. incorporation, with stirring, and at a temperature of less than 40°

C., of the biologically active agent, optionally presolubilized in an appropriate solvent.

16. A regime or regimen for the prevention and/or treatment of a dermatological disease, condition or affliction, comprising topically applying onto the affected skin area of an individual in need of such treatment, a thus effective amount of an oil-in-water emulsion as defined by claim 1.

17. The regime or regimen as defined by claim 16, comprising the treatment of psoriasis.

18. The oil-in-water emulsion as defined by claim 5, in which the propenetrating agent is selected from the group consisting of propylene glycol, dipropylene glycol and propylene glycol dipelargonate.

19. The oil-in-water emulsion as defined by claim 5, in which the propenetrating agent comprises propylene glycol.

20. The oil-in-water emulsion as defined by claim 1, in which the biologically active agent comprises clobetasol 17-propionate.